Table 3.
Results of a subgroup analysis of mean SBM by sex, age, race, and SBM at baseline
| Mean SBM count (SD), n | Lubiprostone sprinkle (n = 234) | Lubiprostone capsule (n = 113) | Placebo (n = 126) | |||
|---|---|---|---|---|---|---|
| Baseline | Week 1 | Baseline | Week 1 | Baseline | Week 1 | |
| Sex | ||||||
| Male | 1.3 (0.67), 32 | 3.1 (2.04), 32 | 1.3 (0.66), 21 | 5.2 (3.72), 21 | 1.3 (0.49), 21 | 3.1 (1.61), 21 |
| Female | 1.4 (0.70), 202 | 5.1 (3.79), 202 | 1.3 (0.74), 92 | 5.9 (3.81), 92 | 1.4 (0.73), 105 | 3.8 (2.25), 105 |
| Age | ||||||
| < 65 | 1.4 (0.70), 213 | 4.8 (3.75), 213 | 1.4 (0.71), 100 | 5.7 (3.80), 100 | 1.4 (0.68), 118 | 3.7 (2.14), 118 |
| ≥ 65 | 1.4 (0.58), 21 | 4.8 (2.62), 21 | 1.3 (0.83), 13 | 6.3 (3.79), 13 | 1.2 (0.88), 8 | 3.0 (2.51), 8 |
| Race | ||||||
| White | 1.3 (0.66), 120 | 4.7 (3.60), 120 | 1.3 (0.69), 59 | 4.9 (2.87), 59 | 1.4 (0.7), 71 | 3.6 (1.97), 71 |
| Non-white | 1.4 (0.73), 114 | 4.9 (3.73), 114 | 1.4 (0.76), 54 | 6.6 (4.45), 54 | 1.3 (0.69), 55 | 3.7 (2.41), 55 |
| SBM at baseline | ||||||
| < 1.5 | 0.8 (0.46), 102 | 4.3 (3.20), 102 | 0.7 (0.42), 47 | 5.7 (4.89), 47 | 0.8 (0.46), 56 | 3.2 (2.10), 56 |
| ≥ 1.5 | 1.8 (0.43), 132 | 5.2 (3.94), 132 | 1.8 (0.43), 66 | 5.7 (2.79), 66 | 1.9 (0.40), 70 | 4.1 (2.15), 70 |
SBM spontaneous bowel movement, SD standard deviation